The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects

NCT00884091 ·Status: COMPLETED

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

NCT06679270 ·Status: RECRUITING ·Phase: PHASE3

Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes

NCT01157403 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

NCT02473809 ·Status: COMPLETED ·Phase: PHASE4

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

NCT02598791 ·Status: COMPLETED ·Phase: NA

Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

NCT01790308 ·Status: UNKNOWN ·Phase: PHASE4

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

NCT00862589 ·Status: COMPLETED ·Phase: NA

Gut Hormones and Bone Remodeling in Humans (KS-2)

NCT03573934 ·Status: COMPLETED ·Phase: NA

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

NCT00561704 ·Status: COMPLETED ·Phase: NA

Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

NCT06825182 ·Status: RECRUITING ·Phase: PHASE3

Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists

NCT06818292 ·Status: COMPLETED ·Phase: NA

The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies

NCT06173934 ·Status: RECRUITING ·Phase: NA

Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity

NCT02518737 ·Status: COMPLETED

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

NCT00612625 ·Status: COMPLETED ·Phase: NA

Investigation of GLP-2 Mechanism of Action (GA-8)

NCT03159741 ·Status: COMPLETED ·Phase: NA

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

NCT02370745 ·Status: COMPLETED ·Phase: NA

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

NCT06725693 ·Status: RECRUITING

Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy

NCT04216849 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Lypo-hypertrofia Characterization in Diabetes

NCT02278926 ·Status: COMPLETED

Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.

NCT00705952 ·Status: COMPLETED ·Phase: NA

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia

NCT00418288 ·Status: COMPLETED ·Phase: NA

Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

NCT03509324 ·Status: COMPLETED ·Phase: PHASE4

The Role of Incretins in Bone Remodeling in Humans

NCT03966261 ·Status: TERMINATED

Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

NCT02129985 ·Status: UNKNOWN ·Phase: PHASE4

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3